{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T01:51:23Z","timestamp":1772589083737,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.tmrv.2022.09.005","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T02:43:24Z","timestamp":1664765004000},"page":"10-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Plasma Exchange in Alzheimer's Disease"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0924-7558","authenticated-orcid":false,"given":"Lucas","family":"Rohrer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muharrem","family":"Yunce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Montine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2022.09.005_bib0001","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2017\/27073.10480","article-title":"Therapeutic plasma exchange - an emerging treatment modality in patients with neurologic and non-neurologic diseases","author":"Bobati","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0002","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1744-9987.1997.tb00020.x","article-title":"Historical perspective on plasmapheresis","volume":"1","author":"Kambic","year":"1997","journal-title":"Therapeut Apher"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0003","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice \u2013 evidence-based approach from the writing committee of the American society for apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0004","series-title":"Alzheimer's disease","author":"Kumar","year":"2021"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0005","unstructured":"Centers for Disease Control and Prevention. Leading causes of death 2021. Available at: https:\/\/www.cdc.gov\/nchs\/fastats\/leading-causes-of-death.htm (Accessed August 23, 2022)."},{"key":"10.1016\/j.tmrv.2022.09.005_bib0006","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer's disease and other dementias, 1990\u20132016: a systematic analysis for the global burden of disease study","volume":"18","author":"Nichols","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0007","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study","volume":"7","author":"Nichols","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National institute on aging-alzheimer's association guidelines for the neuropathologic assessment of alzheimer's disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0009","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.add9993","article-title":"Blots on a field?","volume":"377","author":"Piller","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0010","unstructured":"Alzheimer's association. stages of alzheimer's 2022. Available at: https:\/\/www.alz.org\/alzheimers-dementia\/stages (Accessed August 23, 2022)."},{"key":"10.1016\/j.tmrv.2022.09.005_bib0011","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3233\/JAD-200786","article-title":"Severity distribution of alzheimer's disease dementia and mild cognitive impairment in the framingham heart study","volume":"79","author":"Yuan","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0012","series-title":"Cognitive screening instruments: a practical approach","author":"Larner","year":"2013"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0013","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-190507","article-title":"Developing effective alzheimer's disease therapies: clinical experience and future directions","volume":"71","author":"Elmaleh","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0014","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of alzheimer's disease","volume":"369","author":"Doody","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0015","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1001\/jama.2009.1866","article-title":"Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial","volume":"302","author":"Green","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0016","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001615RRR","article-title":"Albumin protects the liver from tumor necrosis factor \u03b1-induced immunopathology","volume":"35","author":"Duran-G\u00fcell","year":"2021","journal-title":"FASEB J"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103164","article-title":"Emerging insights into the role of albumin with plasma exchange in Alzheimer's disease management","volume":"60","author":"Costa","year":"2021","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0018","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3233\/JAD-180243","article-title":"Increased albumin oxidation in cerebrospinal fluid and plasma from alzheimer's disease patients","volume":"63","author":"Costa","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0019","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3233\/JAD-130914","article-title":"Posttranslational nitro-glycative modifications of albumin in alzheimer's disease: implications in cytotoxicity and amyloid-\u03b2 peptide aggregation","volume":"40","author":"Ramos-Fern\u00e1ndez","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0020","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1038\/s41598-022-16452-4","article-title":"Severe and long-lasting alteration of albumin redox state by plasmapheresis","volume":"12","author":"Boss","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0021","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1471-4159.2004.02385.x","article-title":"Clearing amyloid through the blood-brain barrier","volume":"89","author":"Zlokovic","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0022","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.csbj.2019.06.017","article-title":"Human albumin impairs amyloid \u03b2-peptide fibrillation through its c-terminus: from docking modeling to protection against neurotoxicity in alzheimer's disease","volume":"17","author":"Pic\u00f3n-Pag\u00e8s","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0023","doi-asserted-by":"crossref","first-page":"32916","DOI":"10.1074\/jbc.271.51.32916","article-title":"Amyloid \u03b2-peptide is transported on lipoproteins and albumin in human plasma","volume":"271","author":"Biere","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0024","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1006\/bbrc.2000.2222","article-title":"Amyloid-\u03b2 peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma","volume":"268","author":"Kuo","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0025","doi-asserted-by":"crossref","first-page":"28163","DOI":"10.1074\/jbc.C112.360800","article-title":"Human serum albumin can regulate amyloid-\u03b2 peptide fiber growth in the brain interstitium","volume":"287","author":"Stanyon","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0026","doi-asserted-by":"crossref","first-page":"e815","DOI":"10.1212\/WNL.0000000000010005","article-title":"Serum albumin and beta-amyloid deposition in the human brain","volume":"95","author":"Kim","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0027","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1471-4159.2002.00889.x","article-title":"Plaque-associated disruption of CSF and plasma amyloid-\u03b2 (A\u03b2) equilibrium in a mouse model of Alzheimer's disease","volume":"81","author":"DeMattos","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0028","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12987-016-0038-x","article-title":"Inhibition of ADAM10 promotes the clearance of A\u03b2 across the BBB by reducing LRP1 ectodomain shedding","volume":"13","author":"Shackleton","year":"2016","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0029","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-\u03b2 peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0030","doi-asserted-by":"crossref","first-page":"15154","DOI":"10.1074\/jbc.M112.439570","article-title":"A lipoprotein receptor cluster IV mutant preferentially binds amyloid-\u03b2 and regulates its clearance from the mouse brain","volume":"288","author":"Sagare","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120056","article-title":"Out with the old, in with the new: Could plasma exchange be used to fill a therapeutic gap in neurology?","volume":"432","author":"Spencer","year":"2022","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.01036","article-title":"Albumin exchange in Alzheimer's disease: might csf be an alternative route to plasma?","volume":"10","author":"Menendez-Gonzalez","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0033","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/156720510790274392","article-title":"Serum albumin concentration and cognitive impairment","volume":"7","author":"Llewellyn","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0034","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/ageing\/afn102","article-title":"Albumin, haemoglobin, BMI and cognitive performance in older adults","volume":"37","author":"Ng","year":"2008","journal-title":"Age Ageing"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0035","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/alz.12137","article-title":"A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study","volume":"16","author":"Boada","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0036","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1358\/dnp.2009.22.6.1395256","article-title":"Amyloid-targeted therapeutics in Alzheimer's disease: Use of human albumin in plasma exchange as a novel approach for abeta mobilization","volume":"22","author":"Boada","year":"2009","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0037","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/JAD-160565","article-title":"Efficacy and safety of plasma exchange with 5% albumin to modify cerebrospinal fluid and plasma amyloid-\u03b2 concentrations and cognition outcomes in alzheimer's disease patients: a multicenter, randomized, controlled clinical trial","volume":"56","author":"Boada","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0038","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/JAD-170693","article-title":"Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin","volume":"61","author":"Cuberas-Borr\u00f3s","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0039","article-title":"Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study","author":"Boada","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jneuroim.2010.09.015","article-title":"Plasma exchange and intravenous immunoglobulins: Mechanism of action in immune-mediated neuropathies","volume":"231","author":"Lehmann","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0041","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trci.2019.01.001","article-title":"Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress","volume":"5","author":"Boada","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0042","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1212\/WNL.0000000000003904","article-title":"A phase 3 trial of IV immunoglobulin for Alzheimer disease","volume":"88","author":"Relkin","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0043","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/1744-9987.12067","article-title":"Russian pioneers of therapeutic hemapheresis and extracorporeal hemocorrection: 100-year anniversary of the world's first successful plasmapheresis","volume":"18","author":"Sokolov","year":"2014","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0044","article-title":"Urbas: Iberia Preview","author":"Smyth","year":"2008","journal-title":"Bloomberg"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0045","unstructured":"Grifols increases its revenues to 5,340 M\u20ac and continues to demonstrate its resilience and commitment to sustainable growth. Barcelona: 2021. https:\/\/www.grifols.com\/en\/view-news\/-\/news\/grifols-increases-its-revenues-to-5340-m-and-continues-to-demonstrate-its-resilience-and-commitment-to-sustainable-growth. [Accessed 25 April 2022]."},{"key":"10.1016\/j.tmrv.2022.09.005_bib0046","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/lt.25384","article-title":"The unclear benefit of albumin","volume":"25","author":"Con","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.tmrv.2022.09.005_bib0047","unstructured":"American Society of Hematology. Nationwide shortage of immunoglobulin forces patients to find alternatives. Washington DC: 2019. https:\/\/ashpublications.org\/ashclinicalnews\/news\/4593\/Nationwide-Shortage-of-Immunoglobulin-Forces. [Accessed 25 April 2022]."},{"key":"10.1016\/j.tmrv.2022.09.005_fur1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3233\/JAD-220808","article-title":"High Soluble Amyloid-\u03b242 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer\u2019s Disease-Causing Mutations","volume":"90","author":"Sturchio","year":"2022","journal-title":"J Alzheimers Dis"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796322000487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796322000487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:20:31Z","timestamp":1760138431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796322000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0887796322000487"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2022.09.005","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma Exchange in Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2022.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}